Loading clinical trials...
Loading clinical trials...
To test the hypothesis that both lack and excess of growth hormone (GH) is associated with cardiac abnormalities. Cardiac function and morphology will be evaluated by MRI before and after treatment.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Herlev Hospital
NCT07333521 · Isolated Non-acquired Growth Hormone Deficiency
NCT07412782 · Osteogenesis Imperfecta, Osteoporosis, and more
NCT05775523 · Growth Hormone Deficiency
NCT00227253 · Chromosome Aberrations, Growth Hormone Deficiency, and more
NCT05698277 · Congenital Heart Defect, Cardiac Function
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions